Aneuploidy, deviation from the normal chromosome number, and other chromosomal aberrations are commonly observed in cancer. Integrin-mediated adhesion and dynamic turnover of adhesion sites are required for successful cytokinesis of normal adherent cells and impaired cell division can lead to the generation of cells with abnormal chromosome contents. We find that repeated cytokinesis failure, due to impaired integrin traffic alone, is sufficient to induce chromosome aberrations resulting in the generation of aneuploid cells with malignant properties. Here, we have compared isogenic aneuploid and euploid cell lines with unravel aneuploidy-induced changes in cellular signaling. Euploid, non-transformed, and aneuploid, transformed, cell lines were investigated using genome-wide gene expression profiling, analysis of deregulated biological pathways and array-comparative genomic hybridization. We find that aneuploidy drives malignancy via inducing marked changes in gene and micro RNA expression profiles and thus imposing specific growth and survival promoting alterations in cellular signaling. Importantly, we identify Twist2 as a key regulator of survival, invasion and anchorage-independent growth in the aneuploid cells. In addition, alterations in lipid biosynthetic pathways and miR-10b upregulation are likely contributors to the malignant phenotype.
Introduction
Chromosomal aberrations are common in many types of cancer and severe aneuploidy has been shown to correlate with high-grade metastatic tumors (1) . However, induction of aneuploidy often leads to an overall reduction in cell fitness, such as defects in cell cycle progression, alterations in metabolic processes and increased sensitivity to inhibitors against protein synthesis and folding (2, 3) . An important question is whether all cells respond to aneuploidy in a similar way and adapt their transcriptional profiles to cope with the detrimental effects of aneuploidy. The gene expression changes that allow for proliferation in an aneuploid state could enable selection of transformed cells. Aneuploidy has been shown to confer adaptive phenotypes under stress (4) and promote transformation in different experimental models of aneuploidy (5) (6) (7) . However, driving functions of aneuploidy and specific molecular changes leading to malignancy have been incompletely characterized.
Endocytosis and membrane traffic of different cargo, including integrins, are required for completion of normal cell division, mainly at the stage of cytokinesis (8, 9) . The importance of integrin traffic has mainly been attributed to regulation of cell migration and linked to motility and invasion in vitro and in vivo (10) (11) (12) . However, spatially and temporally regulated integrin traffic is also critically important for the successful execution of cytokinesis. We have recently shown that impaired integrin traffic is sufficient to induce aneuploidy and malignant transformation such that these aneuploid cells are tumorigenic in vivo (13) . Thus, the established links between endocytosis and cancer are also linked to the role of membrane traffic in mitosis (14) .
Two types of genetic instabilities are characteristic to tumor cells: whole-chromosome instability, brought about by mitotic and cytokinetic errors (15) (16) (17) and structural level DNA instability including chromosomal deletions and translocations (18) . Recently, both forms of instability were shown to be induced by chromosome segregation errors (19) . In agreement with this new insight into the role of wholechromosome instability in cancer, we find that repeated cytokinesis failure due to impaired integrin traffic alone is sufficient to induce chromosome aberrations including altered chromosome number and structural chromosomal alterations (ref. 13 and this study).
Here, we show that cytokinesis failure in mouse embryonic fibroblasts (MEFs) generates an aneuploid and transformed cell population that displays changes in gene expression. Using genome-wide gene expression profiling, analysis of deregulated biological pathways and array-based comparative genomic hybridization (aCGH), we have identified alterations that contribute to the aneuploidy-induced cell transformation. These include a copy number gain and elevated expression of the transcription factor Twist2, possibly acting through alterations of micro RNA (miRNA) expression and by correlating with alterations in lipid metabolism. Importantly, the malignancy of the cells was partially reversed upon RNAi-mediated silencing of twist2 or inhibition of SREBP transcription factors, which control fatty acid and cholesterol synthesis.
Materials and methods

Cell culture
MEFs from β1wt and β1YYFF mice were prepared from E13.5 embryos of heterozygous matings as described previously (20) . Cells were immortalized with the SV40 large T as described by Pellinen et al. (8) and cultured in highglucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM l-glutamine and 1% penicillin/streptomycin. Small interfering RNA (siRNA)-mediated silencing was done using HiPerfect transfection reagent (Qiagen).
Chromosome spreads and mFISH analysis
Chromosome spreads were performed as described (13) . Briefly, after 5 h incubation with 1 μM nocodazole, cells were pelleted and resuspended in 75 mM KCl. Cells were fixed (3:1 methanol:acetic acid) overnight, washed and dropped onto a microscope glass before drying and mounting with Vectashield (Vector Labs) containing 4′,6-diamidino-2-phenylindole.
Cell proliferation, apoptosis and invasion assays
Proliferation assays were performed as described (13) . In addition, 10 × 10 3 cells in 100 μl medium were plated on ultralow attachment 96-well plates (Corning) for measuring anchorage-independent proliferation with WST-1 reagent (Roche Applied Science). Absorbance was measured at 450 nm on Envision™ Multilabel Plate Reader (PerkinElmer) after 1 h incubation at 37°C with 10 μl WST-1. For the apoptosis assays, 10 × 10 3 cells in 100 μl medium were plated on 96-well plates (Corning) for measuring apoptosis with caspase glow reagent according to manufacturer's instructions (Promega). Invasion assays were performed as described in Högnäs et al. (13) . For RNAi-mediated silencing, siRNA transfections were done 1 day before plating the cells on 8-well μ-Slides (ibidi GmbH).
Abbreviations: aCGH, array-based comparative genomic hybridization; HA, hyaluronan; Has1, hyaluronan synthase 1; MEF, mouse embryonic fibroblast; miRNA, micro RNA; mRNA, messenger RNA; qRT-PCR, quantitative reverse transcription-polymerase chain reaction; siRNA, small interfering RNA.
Aneuploidy induces Twist2
Gene expression A genome-wide gene expression profiling assay, as well as a complete data analysis service, was ordered from the Finnish DNA Microarray Centre at Turku Centre for Biotechnology. The array type used was Illumina Sentrix® Mouse Ref-8 v2.0 Expression Bead Chips and each array on the chips contained probe sequences targeted for 25 697 transcripts derived from the NCBI RefSeq database. All the analyses were performed with the R language and environment for statistical computing. Pearson's metrics was used in the correlation analysis to describe the similarity between all samples. In hierarchical clustering, the samples are grouped according to their general similarity with Pearson's metrics corresponding to the correlation analysis. Sample group comparisons were performed using the R package Limma that determines the differentially expressed genes between two sample groups and filters the transcripts to list those that are strongest and most reliably altered. The filtering parameters were based on fold change of the transcripts and P-value. Limma calculates a false discovery rate corrected P-value and this threshold was set to 0.001.
Immunocytochemistry
MEF cells were plated on acid-washed glass coverslips. Cells were fixed with 3.7% paraformaldehyde in phosphate-buffered saline, permeabilized with 0.2% Triton X-100 in phosphate-buffered saline for 15 min and blocked in 2% bovine serum albumin/phosphate-buffered saline. Primary antibodies were used with predetermined optimal concentrations (5-10 µg/ml). The concentration of Alexa-conjugated secondary antibodies or Alexa-conjugated phalloidin (Invitrogen) was 5 or 20 µg/ml, respectively. Coverslips were mounted with Vectashield mounting medium (Vector Labs) containing 4′,6-diamidino-2-phenylindole for nuclear staining. Immunofluorescent samples were analyzed with a Zeiss-inverted wide-field microscope with or without confocal unit using Zeiss Plan-Neofluar 63xoil/1.4 NA objective complemented with MetaMorph imaging software. Maximum projections of images were created from Z-stacks (step interval 0.2-2 µm).
Statistics
Statistical analysis was performed with the two-sample Student's t-test, unless stated otherwise.
Accession numbers
The results from the Illumina microarray gene expression assay have been deposited to the Gene Expression Omnibus (GEO) database with the accession number GSE23729.
Results
Repeated cytokinesis failure in β1YYFF MEFs results in formation of aneuploid and transformed cells
We have recently shown that defects in integrin traffic lead to aneuploidy and oncogenic transformation in vitro and in vivo (13). However, the molecular level alterations underlying the malignant transformation of such aneuploid cells remain uninvestigated. Trafficking of integrins is required for completion of cytokinesis (8), so we used wild-type MEFs or MEFs harboring a germline tyrosine to phenylalanine mutation in their β1-integrin (β1YY783, 795FF) that causes reduced integrin endocytosis (8) to investigate aneuploidyrelated molecular changes in these isogenic cell lines. The β1YYFF mutant MEFs fail to execute cytokinesis on β1-specific matrixes, such as laminin and collagen (8) , whereas the β1wt cells undergo normal cell division. To induce repeated cycles of cytokinesis failure, β1wt and β1YYFF MEFs were plated on laminin and the cells underwent one cycle of cell division on this matrix. Fetal bovine serum (10%) was then added to the medium (adhesion is thus mediated via β3-integrins and cytokinesis is executed normally) and the cells were grown to confluency. Passaging on laminin was repeated four or eight consecutive times (indicated by L4 and L8) and all cells from the surviving populations were subsequently grown under normal conditions on plastic after which the cells were analyzed ( Figure 1A ). The wild-type and mutant cell lines have both undergone spontaneous tetraploidization, but not transformation, due to SV40 large T immortalization (6) and we have shown previously that four passages on laminin lead to near-triploid aneuploidy and transformation in β1YYFF cells, whereas β1wt cells do not show hallmarks of transformation and retain their initial stable tetraploid karyotype (6) (and Supplementary Figure S1A -C, available at Carcinogenesis Online).
Here we show that the β1YYFF_L8 cells, which have undergone four additional passages on the β1-specific matrix, have also acquired an aneuploid karyotype ( Figure 1B ) and show similar phenotypic changes as the β1YYFF_L4 cells. The β1YYFF_L8 cells have reduced proliferation on plastic compared with β1wt_L8 cells ( Figure 1C ), which reflects a growth disadvantage associated with aneuploidy under normal culture conditions (2, 3) . However, the β1YYFF_L8 cells display increased anchorage-independent proliferation and invasiveness in vitro ( Figure 1D and E), which are both important characteristics of malignant cells. In contrast, β1wt_L8 cells are largely unaffected by the laminin passaging and do not show any change in ploidy or transformation potential (Figure 1 ).
To test whether the malignant changes in the cellular phenotype represented a common response to aneuploidy induced by defects in integrin traffic, we used another clone of the wild-type and β1YYFF MEFs (clone B) and subjected them to the same laminin treatment (four passages only) to induce cytokinesis failure. Similar to β1YYFF_L4 clone A, the B clone β1YYFF_L4 cells (here termed β1YYFF_L4b) had a modal chromosome number of 64 (6) . They also display similar phenotypic features associated with aneuploidy and malignancy, such as slow proliferation on plastic (Supplementary Figure S1D , available at Carcinogenesis Online), but increased anchorage-independent proliferation and foci formation (Supplementary Figure S1E and F, available at Carcinogenesis Online) compared with the tetraploid cells. Together, these results show that repeated cytokinesis failure in MEFs leads to generation of aneuploid and transformed cell populations.
β1YYFF_L4 and β1YYFF_L8 cells exhibit aneuploidy-specific gene expression changes
In order to identify aneuploidy-induced changes in gene expression, we compared the gene expression profiles of wild-type MEFs (L0, L4 and L8) and β1YYFF mutant MEFs (L0, L4 and L8). The samples were grouped in hierarchical clustering according to similarity based on correlation analysis ( Figure 2A ). Interestingly, the tetraploid β1YYFF_L0 and the β1wt samples were more similar with one another than with the aneuploid laminin-treated β1YYFF samples (L4 and L8). This suggests that induction of aneuploidy and the resulting transformation have fundamentally altered the gene expression profile of these cells. In line with this, there were no major differences in the total amount of genes that were differentially expressed between the wild-type sample groups ( Figure 2B ). Conversely, the gene expression profiles of the tetraploid β1YYFF_L0 and aneuploid β1YYFF_L4 cells differed significantly from each other. Interestingly, when using a fold change threshold of four, no differences were detected between the β1YYFF_L4 and the β1YYFF_L8 samples ( Figure 2B ). This suggests that additional plating on laminin after the initial four passages did not substantially alter gene expression. This is probably due to the regained ability of the β1YYFF_L4 cells to endocytose β1-integrin (13) allowing these cells to complete cytokinesis on laminin. Altogether, 157 genes were uniquely up-or downregulated in β1YYFF_L4 (A clone) compared with the β1YYFF_L0 cells with an >4-fold difference in expression level (Supplementary  Table S1 , available at Carcinogenesis Online). The differential expression of genes identified by the microarray was also verified using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) ( Figure 2C ). The gene expression profiles of wild-type and β1YYFF MEFs of the B clone were also studied (L0 and L4) and aneuploidy-induced changes analyzed. Similar to the A clone, significant alterations in gene expression were observed to correlate with aneuploidy. However, the gene expression changes seemed to be less robust than in the A clone, as only 59 genes were uniquely altered with >4-fold difference in expression level (Supplementary  Table S2 , available at Carcinogenesis Online). Importantly, Ingenuity Pathways Analysis revealed that several key biological functions and signaling pathways were commonly affected in both of the aneuploid cell lines (A and B clones), albeit the differentially expressed genes were not identical. Among the top biological functions associated with aneuploidy in both A and B clones were 'cancer', 'cellular growth and proliferation' and 'cellular movement' ( Figure 2D ). Ingenuity Pathways Analysis also generates networks of interactions from the up-and downregulated genes. The most significant network included genes involved in 'lipid metabolism, small molecule biochemistry, vitamin and mineral metabolism' (Supplementary Figure S2A , available at Carcinogenesis Online). In addition, the top transcription factors predicted to be activated in the aneuploid cells were the master regulators of fatty acid and cholesterol synthesis Srebf1 and Srebf2 (Supplementary Figure S2B , available at Carcinogenesis Online). This effect on lipid metabolism was also reflected in the canonical pathways enriched in this data set, where 'biosynthesis of steroids' was one of the top pathways affected (Supplementary Figure S2C , available at Carcinogenesis Online). In addition, the quantity of lipid was also predicted to be increased with a z-score of 2.242 according to the Ingenuity Pathways Analysis (Supplementary Figure S2D , available at Carcinogenesis Online). These results show that the aneuploid cells have acquired gene expression changes, which are associated with cancer and metabolic alterations. The putative increase in lipid synthesis would correlate well with the altered metabolism of transformed cells (21,22) . 
β1YYFF_L4 cells display upregulation of the transcription factor Twist2
To elucidate in more detail the signaling changes that contribute to oncogenic transformation, we studied the genes that were significantly affected by the induction of aneuploidy in the A clone. The most upregulated gene was hyaluronan synthase 1 (Has1), one of the enzymes that synthesizes the glycosaminoglycan hyaluronan (HA). Has1 was more than 300-fold upregulated in the β1YYFF_L4 cells, although based on aCGH analysis the Has1 gene was not located in a region of a copy number gain on chromosome 17 (Supplementary Figure S3A, (23) . However, silencing Has1 or preventing HA-CD44 binding using a CD44 blocking antibody did not reduce anchorageindependent growth or the ability of the β1YYFF_L4 to invade into Matrigel (data not shown and Supplementary Figure S3D , available at Carcinogenesis Online).
In addition to Has1, the muscle-specific α7-integrin was also highly upregulated in the β1YYFF_L4 cells on messenger RNA (mRNA) level ( Figure 2C ) and the Itga7 gene was located in a slightly gained region on chromosome 10 (Supplementary Figure S4A , available at Carcinogenesis Online). We also detected increased α7-integrin surface expression and α7-integrin localization in especially lamellipodia-like structures in β1YYFF_L4 (Supplementary Figure S4B and C, available at Carcinogenesis Online). However, α7-integrin did not seem to be critical for the invasiveness of the aneuploid cells, as inhibition with an α7-integrin function-blocking antibody had no effect on invasion in Matrigel (Supplementary Figure S4D , available at Carcinogenesis Online).
Twist2 belongs to the family of basic helix-loop-helix transcription factors and it has been shown to have a role in tumor metastasis, induction of epithelial-to-mesenchymal transition in epithelial cells and inhibition of senescence in cancer cells (24) . Twist2 was also among the upregulated genes in the gene expression microarray analysis and a 4.3-fold increase in Twist2 expression in β1YYFF_L4 compared with β1YYFF_L0 was confirmed with qRT-PCR ( Figure 3A ). In addition, the aCGH demonstrated that the chromosomal region of the Twist2 was located in a region of a copy number gain on chromosome 1 in the β1YYFF_L4 cells compared with β1YYFF_L0 cells ( Figure 3B ) and increased levels of Twist2 protein were detected in the nuclei of β1YYFF_L4 when compared with tetraploid cells (Figure 3C and D) . Given its function as a transcription factor, further studies were carried out to determine if the upregulation and nuclear localization of Twist2 would have a role in the transformed phenotype. Interestingly, RNAi-mediated silencing of Twist2 reduced anchorage-independent growth in the aneuploid cells ( Figure 4A ), increased apoptosis in these cells under normal culture conditions ( Figure 4B ) and significantly decreased their ability to invade into Matrigel ( Figure 4C and D) . However, overexpression of Twist2 alone was not sufficient to transform MEFs since Twist2 expression did not result in increased proliferation or invasion into Matrigel in the tetraploid control cells (Supplementary Figure S5A and B, available at Carcinogenesis Online). Taken together, these data demonstrate that Twist2 expression is necessary for many of the transformed characteristics in these cells but is not alone sufficient to induce them in cells. Thus, the altered phenotype in the aneuploid cells is a function of several different genetic alterations and Twist2 is an important signaling node in this context.
The transcription factor Twist1 drives cell migration and invasion in metastatic breast cancer by upregulation of miR-10b (25, 26) . Using an RT 2 miRNA PCR Array, we studied differential expression of several miRNAs previously linked to cancer (Supplementary Figure S5C , available at Carcinogenesis Online) and detected a 2.7-fold upregulation of miR-10b in the β1YYFF_L4 cells ( Figure 4E ). We also found that similar to Twist1 in breast cancer cells, Twist2 expression correlated with miR-10b levels in MEFs. siRNA-mediated silencing of Twist2 in the aneuploid β1YYFF_L4 and β1YYFF_L8 cells downregulated miR-10b levels ( Figure 4F ) such that 90% reduction of Twist2 mRNA levels resulted in a 60% reduction of miR-10b. In addition, 16 other cancer-related miRNAs were differentially expressed in the aneuploid cells, highlighting the biological complexity associated with transition of cells to a malignant state. Thus, aneuploidy-induced transformation and the genetic evolution related to it may also involve alterations in miRNA expression.
Twist2 is involved in lipid metabolism
In brown adipose tissue of the mouse, Twist1 inhibits PGC-1α transcriptional activity, leading to reduced fatty acid oxidation and increased lipid accumulation (27) . Twist2 has been shown to bind to SREBP1c in vitro and attenuate the transcriptional activation of SREBP1c, but not SREBP2 (28) . In addition, the Twist2 KO mice display adipose deficiency in many tissues and abnormalities in glycogen storage (29) . Thus, we wanted to test if upregulation of Twist2 would correlate with the differential expression of lipid-related genes detected in the aneuploid β1YYFF_L4 cells. We tested the effect of Twist2 silencing on the expression levels of 94 genes involved in lipoprotein signaling and cholesterol metabolism. Overall, Twist2 levels correlated with the expression of many SREBP1/2-regulated genes, which is in line with the SREBP signature detected in the Illumina array ( Figure 5A ). Interestingly, Twist2 downregulation also affected the expression of additional genes in the array (Figure 5B ), suggesting that the expression of this transcription factor correlates with gene expression changes related to lipid metabolic processes. Since Twist2 silencing reduced the levels of several target genes of the SREBP transcription factors as well as SREBP1 and 2 themselves, we wanted to investigate the relevance of this pathway further. Fatostatin, a recently described inhibitor of SREBP activation (30) , significantly reduced the anchorage-independent proliferation of the β1YYFF_L4 cells in a manner similar to silencing of Twist2 ( Figure 5C ). Taken together, we have shown here that upregulation of Twist2 is linked to several malignant alterations like anchorage-independent growth, survival, invasion, miRNA expression and altered metabolism of the aneuploid cells.
Twist2 expression detected in tumors
Upregulation of Twist2 has been detected in especially esophageal squamous cell carcinomas (24) and correlates with poor prognosis in head and neck squamous cell carcinomas (31) as well as cervical cancer progression (32) . However, expression of Twist2 in different cancer types has not been extensively studied, especially in tumors of mesenchymal origin. Aneuploid β1YYFF cells are tumorigenic in based on correlation analysis. β1YYFF_L0 and the β1wt samples were more similar with one another than the β1YYFF_L0 and the aneuploid β1YYFF samples (L4 and L8). (B) MA [visual representation of two channel DNA microarray gene expression data, which has been transformed onto the M (log ratios) and A (mean average) scale] plots of the sample group comparisons are shown. The log2-transformed fold change is represented on the y-axis and the log2-transformed average intensity of the sample groups is represented on the x-axis. The dashed lines show the thresholds for the differentially expressed genes and the result transcripts have been colored red. (C) qRT-PCR verification of differentially expressed genes in the indicated cell lines relative to expression of glyceraldehyde 3-phosphate dehydrogenase (mean ± SEM, n = 3). (D) Comparison of functions associated with the differentially expressed genes in β1YYFF_L4a and β1YYFF_L4b cells. The bar chart displays the most significant functions across the data set (molecular and cellular functions, diseases and disorders and physiological system development and function). The likelihood that the association between a set of genes in the data set and a related function is due to random association is measured. Fisher's exact test is used to measure P-value.
← vivo such that they generate high-grade fibrosarcomas in mice (13) . This prompted us to investigate Twist2 expression in human sarcoma. We found elevated immunohistochemical staining of Twist2 protein in three out of seven human sarcomas (Supplementary Figure S6 , available at Carcinogenesis Online). Taken together, these results demonstrate that high Twist2 protein levels can be detected in human sarcomas. Therefore, it is possible that some of the Twist2-related pathways identified here in the aneuploid cells are also involved in human sarcoma progression, however, that remains to be investigated.
Discussion
The link between aneuploidy and cancer has been known for over a century (33) ; however, it is not entirely clear whether aneuploidy is the cause or the consequence of cancer and what would be the biological outcome of aneuploidy contributing to malignant traits of cancer cells. Here, we have employed a controlled model system to induce aneuploidy by interfering with integrin traffic and cytokinesis. We find that repeated cytokinetic failure is sufficient to induce aneuploid cell lines, which retain altered chromosome numbers and a transformed phenotype. Using gene expression profiling, we compared the aneuploid and euploid isogenic cell lines and observed gene expression alterations in the aneuploid cells. The changes in gene expression and signaling pathways revealed that numerous alterations in gene expression profiles coincide with the aneuploidy induction and most likely the transformed phenotype of the cells is a consequence of several genetic alterations having a synergistic effect on the phenotype. Interestingly, independently generated aneuploid cell lineages displayed upregulation of the same biological functions including 'cancer', 'cellular growth and proliferation' and 'cellular movement'. This suggests that aneuploidy induction is linked to cell transformation and involves upregulation of common cellular traits although the specific genetic alterations may not necessary be identical. Most likely, the selection of surviving cells following aneuploidy induction is context dependent, and the altered pathways facilitating a growth advantage in our model system of fibroblast transformation to sarcoma-generating cells may be different in another cell type.
One of the highly upregulated genes was Has1. The glycosaminoglycan HA is synthesized by specific HA synthases, including Has1, and high levels are often found in malignant tumors (34, 35) . We also observed increased (nearly 2.5-fold) upregulation of CD44, the receptor for HA. Signaling downstream of CD44 and HA has been shown to induce invasion and RhoA activity in different cancers (36) (37) (38) . In this study, analysis of the aneuploid cells validated the high Has1 and HA levels in these cells; however, loss-of-function experiments and function-blocking antibody for CD44 failed to inhibit invasion. Nevertheless, it is plausible that the marked upregulation of this pathway contributes to the malignancy of these cells on another level. For example, as both Has1 and CD44 have been identified as stem cell markers, the aneuploidy-induced changes may have driven the cells to adopt cancer-stem-cell-like characteristics.
The transcription factor Twist2, a close relative to Twist1, was upregulated in the aneuploid β1YYFF_L4a cells and based on the aCGH data, this region of the genome exhibited a copy number change in the aneuploid cells. The Twist proteins have been linked to epithelial-tomesenchymal transition and metastasis (24, 39) . In addition, Twist2 upregulation has been demonstrated in esophageal squamous cell carcinomas (24) and cervical cancer (32), albeit its role in cancer is much less studied than the related transcription factor Twist1 (39) (40) (41) . The model used here employs MEFs that are mesenchymal cells. Thus, the ability of Twist2 to contribute to invasion and malignancy in our aneuploid cells is unlikely to be related to the well-documented role of Twist as an inducer of epithelial-to-mesenchymal transition but would involve other features controlled by this factor. This is underlined by the fact that we detect increased Twist2 expression in some human sarcomas, which are tumors of mesenchymal origin. Importantly, we find that silencing of Twist2 inhibits anchorage-independent growth, survival and invasion of the aneuploid cells. The role in invasion could be linked to Twist2-mediated upregulation of miR-10b, a proinvasive miRNA (25) . Furthermore, our data demonstrate that Twist2 levels correlate with upregulation of several important genes related to the mevalonate pathways and cholesterol metabolism regulated by the SREBP transcription factors.
The link between the mevalonate pathway and cancer has been increasingly investigated recently. Upregulation of several components of this pathway has been linked to multiple aspects of tumorigenesis, including proliferation, survival, invasion and metastasis as well as Fig. 4 . Twist2 regulates anchorage-independent growth, survival, invasion and miRNA expression in β1YYFF_L4a cells. Cells were silenced with the indicated siRNAs, and proliferation (A) or apoptosis (B) was analyzed at the indicated time points. Silencing efficiency was verified using qRT-PCR (relative expression). Shown are representative graphs of two similar experiments (mean ± SEM, n = 4; *P < 0.05, **P < 0.005). Twist2-or Scr siRNA-silenced β1YYFF_L8 (C) or β1YYFF_L4 (D) cells invading in Matrigel (mean ± SEM, n = 8-20; *P < 0.05, ***P < 0.001). Scale bar, 50 µm. (E) Relative expression of miRNA-10b in β1YYFF_L0 and β1YYFF_L4. (F) Relative expression of miRNA-10b and Twist2 mRNA after Twist2 knockdown in β1YYFF_L4 and β1YYFF_L8 cells. disruption of 3D tissue architecture (42) (43) (44) (45) . In addition, a large-scale RNAi screen has recently shown that several genes of the mevalonate pathways as well as the target genes of the SREBP transcription factors as critical regulators of prostate cancer survival (46) . We show here that Twist2 silencing results in decreased expression of Cyp51a, Dhcr24, Fdps, Hmcgs1, Insig1, Insig2, Mvd, Nsdhl, Pmvk, Pcsk9 and Srebf2 genes all of which were upregulated in the aneuploid β1YYFF_L4 cells compared with the parental euploid β1YYFF_L0 cells based on the gene expression analysis. The overlap between the siRNA screen hits and the aneuploidy-induced genes is impressive. siRNAs against Cyp51a, Fdps, Hmcgs1, Dhcr24, Mvd, Nsdhl and Srebf2 inhibited prostate cancer proliferation significantly at least in one of the cell lines included in the study (46) . Furthermore, a recent meta-analysis of breast cancer samples linked five of the Twist2-regulated genes (Fdps, Mvd, Mvk, Hmgcs1 and Hmgcr) to survival (42) and three of these (Fdps, Hmgcs1 and Mvd) were also significantly upregulated in the aneuploid cells. This could be one of the underlying causes for the reduced survival of the aneuploid cells following Twist2 silencing. The importance of deregulated lipid metabolism in tumor progression is also evident by the observation that tumor cells often activate de novo fatty acid synthesis (47) . For example, increased expression of the SREBP1-regulated genes FASN, ACC and SCD has been detected in many types of cancer The effect of Twist2 silencing in β1YYFF_L4 cells on genes that were differentially expressed in the Illumina array. Left, fold change of the indicated genes in β1YYFF_L4 compared with β1YYFF_L0 according to the Illumina array. Right, fold change of the indicated genes in Twist2-silenced β1YYFF_L4 cells compared with control. Shown is mean ± SD from two independent experiments (Twist2 levels 0.37 and 0.23). (B) Effect of Twist2 silencing in β1YYFF_L4 cells on all genes in the PCR array. Shown is mean ± SD from two independent experiments. Only genes that showed consistency in both experiments are shown. (C) Anchorage-independent proliferation on ultralow attachment plates after 72 h with SREBP inhibitor fatostatin. Shown is a representative graph of two similar experiments (mean ± SEM, n = 4; *P < 0.05). (47, 48) . Interestingly, both isoforms Scd1 and Scd2 were found to be upregulated in the aneuploid cells (with a fold change of 4.4 and 6.2, respectively). Therefore, the aneuploidy-induced changes in the metabolic pathways detected in our model system appear to be relevant in human cancer as well. We also found that inhibition of the activation of SREBP transcription factors was sufficient to inhibit anchorage-independent growth in these cells. Thus, even though the detailed analysis of the relevance of the metabolic changes would be subject of a future study, and Twist2 clearly regulates the transformed phenotype of these cells via multiple pathways, these data suggest that such alterations contribute to the malignancy of these cells.
Taken together, our results indicate that aneuploidy initiated by derailed integrin traffic and the resulting transformation induces gene expression changes that facilitate malignant cell behavior.
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